What you’ll discover in this article ・tRNA-based treatments are a promising approach for genetic diseases caused by nonsense ...
Melbourne researchers have made a gene therapy breakthrough that could restore heart function in children with genetic heart ...
Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Kelly ...
Patients with sickle cell disease are often hesitant to undergo transformative gene therapy—the current lengthy process ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Miles, age 2, is one of the first patients at Boston Children's hospital to receive gene ...
Four decades have passed since cochlear implants gave infants born deaf the ability to hear. Now, gene therapy promises to restore natural hearing for those born with a rare form of deafness, and the ...
GENGLYCOS is the first gene therapy approval, and fifth FDA approval overall, for the companyApproval provides a long-awaited first-ever option ...
The FDA has granted accelerated approval of a gene therapy to treat children and adults aged at least 8 years with glycogen ...
For those born with certain types of congenital deafness, the cochlear implant has been a positive and enabling technology. It uses electronics to step in as a replacement for the biological ear that ...
Good afternoon, and welcome to the Ultragenyx Pharmaceutical Conference Call to discuss the U.S. Food and Drug Administration approval of GENGLYCOS known as DTX401 for the treatment of glycogen ...
Everett, 16 months, was the first patient at Boston Children’s Hospital to receive the gene therapy treatment ...